A Study of Retatrutide (LY3437943) Once Weekly in Participants Who Have Obesity or Overweight and Osteoarthritis of the Knee

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

405

Participants

Timeline

Start Date

August 1, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
ObesityOverweightOsteo Arthritis Knee
Interventions
DRUG

Retatrutide

Administered SC

DRUG

Placebo

Administered SC

Trial Locations (49)

2019

Emeritus Research, Botany

2148

Paratus Clinical Research Western Sydney, Blacktown

2617

Paratus Clinical Research Canberra, Bruce

3124

Emeritus Research, Camberwell

3220

Barwon Health, Geelong

4029

Royal Brisbane and Women's Hospital, Brisbane

4064

Core Research Group, Brisbane

4558

CDH Research Institute, Maroochydore

14004

Hospital Universitario Reina Sofia, Córdoba

15006

CHUAC-Complejo Hospitalario Universitario A Coruña, A Coruña

15405

"Complejo Hospitalario Universitario de Ferrol (CHUF)- Hospital Naval)", Ferrol

28702

Hospital Universitario Infanta Sofía, San Sebastián de los Reyes

29004

Hospital Quirón Málaga, Málaga

30189

North Georgia Clinical Research, Woodstock

31000

Investigacion y Biomedicina de Chihuahua, Chihuahua City

33135

Suncoast Research Group, Miami

41003

Clínica nuevas Tecnologías en Diabetes y Endocrinología (NTDE), Seville

44210

Consultorio Médico, Guadalajara

46014

Hospital General Universitario de Valencia, Valencia

48706

Great Lakes Research Group, Inc., Bay City

60611

Northwestern University, Chicago

64020

IMED Internal Medicine Clin Trials, Monterrey

64610

Clínica García Flores SC, Monterrey

65807

Clinvest Research LLC, Springfield

66465

Unidad Médica para la Salud Integral, San Nicolás de los Garza

75211

Mercy Family Clinic, Dallas

78229

Clinical Trials of Texas, Inc., San Antonio

83221

Elite Clinical Trials, Blackfoot

85053

Arizona Research Center, Phoenix

89440

Centro de Estudios de Investigacion Metabolicos y Cardiovasculares, Ciudad Madero

92103

Artemis Institute for Clinical Research, San Diego

97070

Kohler and Milstein Research S.A. de C.V., Mérida

98007

Northwest Clinical Research Center, Bellevue

06708

Chase Medical Research, LLC, Waterbury

02451

MedVadis Research Corporation, Waltham

T2V 4J2

C-health Research, Calgary

A1B 3V6

Eastern Health - General Hospital, St. John's

B4V 3N2

Viable Clinical Research, Bridgewater

L8L 5G8

Wharton Medical Clinic, Hamilton

N7T 4X3

Bluewater Clinical Research Group Inc., Sarnia

M1P 2T7

Viable Clinical Research, Scarborough Village

L4A 1H2

Stouffville Medical Research Institute Inc., Stouffville

M3J 0K2

Canadian Phase Onward, Toronto

G2J 0C4

Alpha Recherche Clinique, Québec

G3K 2P8

ALPHA Recherche Clinique, Québec

08041

Hospital de la Santa Creu i Sant Pau, Barcelona

LE5 4PW

Leicester General Hospital, Leicester

EN3 4GS

Panthera Biopartners - North London, Enfield

S2 5FX

Panthera Biopartners - Sheffield, Sheffield

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT05931367 - A Study of Retatrutide (LY3437943) Once Weekly in Participants Who Have Obesity or Overweight and Osteoarthritis of the Knee | Biotech Hunter | Biotech Hunter